Skip to content
Conference Open access

LMNA-NTRK1 fusion–positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report

Sep 2026 · International Cancer Conference Journal · Vol 15, pp. 601 - 607 · 0 citations · 32 references
Medicine
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.